News: Brokerage

CBRE and Savills lease 6,514 s/f to Peachy at 1245 Broadway

Manhattan, NY Corem of Sweden, and GDS Development Management (GDSNY) signed a five-year lease at 1245 Broadway with Peachy, the NYC-based personalized Botox studio focused on wrinkle treatment and prevention, founded by Dr. Carolyn Treasure and Eric Zhang. Peachy has taken 6,514 s/f of office space over a full tower floor.

Peachy currently operates seven retail locations throughout NYC, including in West SoHo, NoMad, NoHo, Williamsburg, Brooklyn Heights, Manhattan West, and Grand Central. Peachy’s fresh approach to preventive science-based skincare offers all the benefits of clinical care in an approachable environment that departs from the sterility of a traditional doctor’s office. Its skincare concept is grounded in a science-based, clinical methodology, and its services include a preventative blend of Botox, prescription retinoids, and daily-use sunscreen for every face and skin type.

 1245 Broadway is a 23-story class-A office building at the corner of 31st St. and Broadway, in NoMAD. Designed by Skidmore, Owings & Merrill, the building features architectural cast-in-place concrete, large triple-glazed windows, a private club, F&B catering to tenant floors, and panoramic views of the city. The building will be LEED-Gold certified and offers the very latest in touchless technology and air quality.

“We are very pleased to announce another signed lease at 1245 Broadway, this time with Peachy. We see a continued trend by premium tenants to high-quality office buildings and consequently a continued recovery in the market for premium office buildings in New York,” said Eva Landén, Corem’s CEO.

 “We are so delighted to welcome another innovator to 1245 Broadway,” said Michael Kirchmann, CEO of GDSNY. “Peachy is a paradigm-breaking company that understands the value that a quality, well-designed office environment brings to their work.”

 GDSNY and Corem were represented by Paul Amrich and Neil King of CBRE. Brandon Cooperstock of Savills represented Peachy.

READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking
The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

July 1, 2025 is the deadline for US banks to begin to adopt Basel III banking standards and July 14, 2025 is the deadline for U.S. banks to adopt ISO 20022 messaging standards. Both will have a significant effect on the banking and commercial real estate (CRE) finance sectors.
Tri-state capital  migrates nationally amid  regulation pressure - by Reese Weaver

Tri-state capital migrates nationally amid regulation pressure - by Reese Weaver

New York tri-state multifamily investors are increasingly reallocating capital to less-regulated markets across the U.S. as rent control and legislative risk erode returns at home. With over 60% of New York City’s rental housing stock classified as rent-stabilized, the traditional value-add model — buying under-performing buildings,

A fresh start - by Shallini Mehra and Amit Doshi

A fresh start - by Shallini Mehra and Amit Doshi

For the past several years, the New York City multifamily housing market has been defined by disruption. The combined impact of the HSTPA rent laws and a sharply higher interest rate environment has fundamentally reduced